What are the symptoms of a pulmonary arteriovenous malformation (AVM) in a patient, potentially with hereditary hemorrhagic telangiectasia (HHT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Pulmonary Arteriovenous Malformations (PAVMs)

Many patients with pulmonary AVMs (25-58%) are completely asymptomatic before catastrophic complications occur, making screening essential in high-risk populations, particularly those with hereditary hemorrhagic telangiectasia. 1

Respiratory Symptoms

  • Hypoxemia is the most common symptomatic presentation, occurring in 27-71% of patients with PAVMs, manifesting either at rest or during exercise 1
  • Dyspnea on exertion affects approximately 67% of symptomatic patients 2
  • Orthodeoxia and platypnea (worsening oxygen levels and shortness of breath when upright) are characteristic presentations because 65-83% of PAVMs are located in the lower lung lobes 1

Neurological Complications

The loss of the pulmonary capillary bed's filtering function creates a direct pathway for emboli to reach the systemic circulation, leading to serious neurological events:

  • Transient ischemic attacks (TIAs) and cerebral strokes occur in 3.2-55% of patients with PAVMs due to paradoxical embolization 1, 3
  • Cerebral abscesses develop in 0-25% of cases when systemic bacterial infections bypass pulmonary filtration 1, 4
  • Major neurologic events were the presenting symptom in 33% of patients in one surgical series 2

These neurological complications represent the most serious morbidity and mortality risk from untreated PAVMs and are the primary indication for treatment 1.

Hemorrhagic Complications

  • Massive hemoptysis and hemothorax are rare (0-2%) but represent life-threatening emergencies 1
  • Pregnancy dramatically increases hemorrhage risk due to hormonal and hemodynamic changes, making this a critical consideration in women of childbearing age 1, 5

Associated Condition: Hereditary Hemorrhagic Telangiectasia (HHT)

  • 70-90% of pulmonary AVMs occur with HHT, an autosomal dominant disorder 1, 3
  • Epistaxis (nosebleeds) is a hallmark of HHT and often present in the patient's history 6
  • Patients may have a family history of HHT 6

Clinical Presentation Patterns

The symptoms depend on the size, number, type (complex versus simple), and flow through the malformations 1:

  • Solitary large PAVMs typically cause more pronounced hypoxemia and may improve after treatment 2
  • Multiple bilateral PAVMs may present with more severe symptoms requiring staged or palliative treatment 2
  • Migraines can occur as a presenting symptom 3

Critical Clinical Pitfall

The high rate of asymptomatic presentation (25-58%) before catastrophic complications mandates aggressive screening in high-risk populations, especially patients with HHT or family history of HHT. 1 Waiting for symptoms to develop before diagnosis can result in preventable strokes, brain abscesses, or fatal hemorrhage. Transthoracic contrast echocardiography with agitated saline has 98-99% sensitivity for detecting PAVMs and should be used as a screening tool in at-risk patients 6.

References

Guideline

Arteriovenous Malformations Clinical Presentation and Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pulmonary arteriovenous malformations: therapeutic options.

The Annals of thoracic surgery, 1993

Research

Pulmonary arteriovenous malformations.

The international journal of cardiovascular imaging, 2019

Guideline

Stable Right Upper Lobe Arteriovenous Malformation (AVM)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.